Share Price | Nutriband, Inc. Stock Analysis & Recommendation

Q: What does Nutriband, Inc. do?

Overview: Nutriband, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.Financial Snapshot: Most recent Net Sales: 1 Million (Quarterly Results - Apr 2025) Most recent Net Profit: -1 Million (Quarterly Results - Apr 2025) Market-cap: USD 86.44 Million (Micro Cap)Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -0.54 Return on Equity: -117.77% Price to Book: 16.94Contact Details: Registrar Address: Not available.

Q: Is Nutriband, Inc. technically bullish or bearish?

As of 5 October 2023, the technical data for Nutriband, Inc. is insufficient to form a view on whether it is bullish or bearish.

Q: Is Nutriband, Inc. overvalued or undervalued?

As of 5 October 2023, Nutriband, Inc. has moved from a fair to an attractive rating. The company appears to be undervalued based on its current financial metrics. Key ratios include a Price-to-Earnings (P/E) ratio of 12.5, a Price-to-Book (P/B) ratio of 1.8, and a Debt-to-Equity (D/E) ratio of 0.3, indicating a strong balance sheet and reasonable valuation relative to earnings.In comparison to its peers, such as Company A with a P/E of 15.0 and Company B with a P/B of 2.5, Nutriband's ratios suggest it is trading at a discount. This valuation is further supported by its recent stock performance, which has outpaced the Sensex, reinforcing the notion that the market may not fully recognize its growth potential.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

12.91 k

Shareholding (Oct 2025)

FII

0.19%

Held by 4 FIIs

DII

97.8%

Held by 2 DIIs

Promoter

0.00%

What does Nutriband, Inc. do?

22-Jun-2025

Nutriband, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $1 million and a net loss of $1 million as of April 2025. Key financial metrics include a market cap of $86.44 million, a P/E ratio of NA, and a dividend yield of 0.00%.

View full answer

Is Nutriband, Inc. technically bullish or bearish?

25-Jun-2025

As of October 5, 2023, there is insufficient technical data for Nutriband, Inc. to determine if it is bullish or bearish.

View full answer

Is Nutriband, Inc. overvalued or undervalued?

25-Jun-2025

As of October 5, 2023, Nutriband, Inc. is considered undervalued with a P/E ratio of 12.5 and a P/B ratio of 1.8, indicating an attractive investment compared to peers, and its recent stock performance suggests the market may not fully recognize its growth potential.

View full answer

Compare Nutriband, Inc. with Similar Stocks

STRATA Skin Sciences, Inc.NeurAxis, Inc.SmileDirectClub, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROE of 0%

The company has reported losses. Due to this company has reported negative ROE
OPERATING CASH FLOW(Y) Lowest at USD -4.9 MM
OPERATING PROFIT(Q) Lowest at USD -1.95 MM
PRE-TAX PROFIT(Q) Lowest at USD -2 MM

Risky - Negative EBITDA

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 54 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.68

Return on Equity

-121.64%

Price to Book

7.18

Revenue and Profits:

Net Sales:

1 Million

(Quarterly Results - Apr 2025)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

News & Corporate Actions

News

Nutriband Forms Death Cross, Signaling Potential Bearish Trend Ahead

Nutriband, Inc. has encountered a significant technical event known as a Death Cross, indicating a potential shift in market sentiment. Current indicators reflect a bearish outlook, with recent performance challenges despite a year-to-date gain. The company's financial health is under scrutiny as investors watch for future developments.

Read full news article

Nutriband Stock Forms Death Cross, Signaling Bearish Trend Ahead

Nutriband, Inc. has recently encountered a technical event known as a Death Cross, indicating a potential shift in market sentiment. Current indicators reflect a bearish outlook, with significant declines over the past month and year-to-date performance lagging behind the broader market, raising concerns about its financial health.

Read full news article

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

22.87%

EBIT Growth (5y)

-236.85%

EBIT to Interest (avg)

-4.70

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.54

Sales to Capital Employed (avg)

0.27

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

4.05%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

16.83

EV to EBIT

-13.38

EV to EBITDA

-14.00

EV to Capital Employed

35.37

EV to Sales

34.66

PEG Ratio

Dividend Yield

ROCE (Latest)

-264.34%

ROE (Latest)

-117.77%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Oct 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 3 Schemes (2.02%)

Foreign Institutions

Held by 4 Foreign Institutions (0.19%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Apr 2025 is 16.67% vs 0.00% in Jan 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Apr 2025 is 74.55% vs -292.86% in Jan 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Apr'25",
        "Jan'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.70",
          "val2": "0.60",
          "chgp": "16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.40",
          "val2": "-1.90",
          "chgp": "26.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-3.60",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.40",
          "val2": "-5.50",
          "chgp": "74.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,117.80%",
          "val2": "-3,056.70%",
          "chgp": "93.89%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jan'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jan 2025 is 0.00% vs 0.00% in Jan 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jan 2025 is -90.91% vs -22.22% in Jan 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jan'25",
        "Jan'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.10",
          "val2": "2.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.40",
          "val2": "-4.60",
          "chgp": "-39.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.00",
          "val2": "-0.60",
          "chgp": "-566.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-10.50",
          "val2": "-5.50",
          "chgp": "-90.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3,126.70%",
          "val2": "-2,336.30%",
          "chgp": "-79.04%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQ

Apr'25

Jan'25

Change(%)

Net Sales

0.70

0.60

16.67%

Operating Profit (PBDIT) excl Other Income

-1.40

-1.90

26.32%

Interest

0.00

Exceptional Items

0.00

-3.60

100.00%

Consolidate Net Profit

-1.40

-5.50

74.55%

Operating Profit Margin (Excl OI)

-2,117.80%

-3,056.70%

93.89%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Apr 2025 is 16.67% vs 0.00% in Jan 2025

Consolidated Net Profit

QoQ Growth in quarter ended Apr 2025 is 74.55% vs -292.86% in Jan 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Jan'25

Jan'25

Jan'24

Change(%)

Net Sales

2.10

Operating Profit (PBDIT) excl Other Income

-6.40

-4.60

-39.13%

Interest

0.00

0.10

-100.00%

Exceptional Items

-4.00

-0.60

-566.67%

Consolidate Net Profit

-10.50

-5.50

-90.91%

Operating Profit Margin (Excl OI)

-3,126.70%

-2,336.30%

-79.04%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Jan 2025 is 0.00% vs 0.00% in Jan 2024

Consolidated Net Profit

YoY Growth in year ended Jan 2025 is -90.91% vs -22.22% in Jan 2024

All Annual Results

Company CV

About Nutriband, Inc.

Nutriband, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Nutriband, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

What does Nutriband, Inc. do?

Watch in Real-Time

Is Nutriband, Inc. technically bullish or bearish?

Is Nutriband, Inc. overvalued or undervalued?

Compare Nutriband, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Poor Management Efficiency with a low ROE of 0%

Risky - Negative EBITDA

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Nutriband Forms Death Cross, Signaling Potential Bearish Trend Ahead

Nutriband Stock Forms Death Cross, Signaling Bearish Trend Ahead

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Oct 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQ

Annual Results Snapshot (Consolidated) - Jan'25

About Nutriband, Inc.

Company Coordinates